Company Overview and News

0
Tata Coffee Q1 net profit down 30.48%

2018-07-26 moneycontrol
Tata Coffee today posted a 30.48 percent drop in its consolidated net profit at Rs 31.22 crore for the quarter ended June 30 against that of Rs 44.91 crore in the year-ago period. Net revenue rose to Rs 422.16 crore during April-June quarter of the 2018-19 fiscal from Rs 367.61 crore in the same period last year, the company said in a regulatory filing.
532301 TATACOFFEE

0
Tata Coffee Limited - Outcome of Board Meeting

2018-07-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532301 TATACOFFEE

0
ITC, Bharti Airtel, Biocon, Maruti, SBI Life results

2018-07-25 thehindubusinessline
Aptech, Agro Tech Foods, Alembic Pharma, Biocon, CESC, Cholamandalam Investment, Bharat Financial, Bharti Airtel, Colgate, Concor, CUB, Dr Reddy’s, Eveready, Heidelberg, ITC, Jubilant, J&K Bank, LV Bank, Maruti Suzuki, NIIT, Quess Corp, Petronet LNG, RS Software, SBI Life, Tata Coffee, Tinplate, Tata Metaliks, Tata Power, Shriram Transport, WABCO and YES Bank are among the 60-odd companies that will declare April-June quarter results on Thursday.
YESBANK ATFL 500215 TATACOFFEE TATAMETALI PQRTY TATAPOWER 513434 532648 YYBKY PETRONET BHRQY 532522 532301 532454 TPCL 500400 BHARTIARTL

4
Podcast | Pick of the day - NCLT okays Tatas#39; bye bye to Cyrus Mistry

2018-07-09 moneycontrol
It appears there is finally some resolution in the eighteen-month-long battle between the Tata Sons and Cyrus Mistry at the National Company Law Tribunal (NCLT). Today, the NCLT dismissed Cyrus Mistry’s plea for his alleged illegal removal from the post of Tata Sons’ Chairman. And that is our Pick of the Day.
500408 TTML TATACOFFEE 500800 BHUSANSTL TTAZF TTQQY BHRQY TATACOMM TTNQY TATACHEM TTAEY 532301 TGBL 500470 532540 TATAINVEST TATASPONGE 501301 500570 BHARTIARTL TATAMOTORS 500770 500055 513010 TGBA TATAMETALI TATAPOWER 513434 532454 TTST TATASTEEL TATLY 532371 TPCL TATAELXSI TCS 500400 500483 TATAGLOBAL TTM

4
NCLT ruling: Tata Motors, Tata Coffee jump 2%, TCS falls over 1%

2018-07-09 thehindubusinessline
Shares of various Tata group companies witnessed a mixed trend after the National Company Law Tribunal (NCLT) dismissed the pleas of Cyrus Mistry against Tata Sons for removing him as Chairman.
TATACOFFEE TATAPOWER TTQQY TTNQY TATACHEM 532301 500470 532540 TTST TATASTEEL TATLY TPCL 500400 TCS 500570 TATAMOTORS 500770 TTM

0
Tata Global Beverages board may weigh revamp plan: N. Chandrasekaran

2018-07-06 livemint
Kolkata: Tata group chairman N. Chandrasekaran on Thursday said the board of Tata Global Beverages Ltd (TGBL) may consider a restructuring proposal to bring together the group’s foods and beverages businesses. On Tuesday, Bloomberg had reported that Tata Chemicals Ltd’s salt and lentils businesses could be carved out and merged with TGBL. Chandrasekaran said there is “no concrete proposal” yet.
532301 TGBL 500800 TATACOFFEE TGBA TTAZF TTQQY TATAGLOBAL 500770 TTAEY TATACHEM

0
Tata considers consolidating food beverages business into a single company: Report

2018-07-04 moneycontrol
Tata Group may integrate its food and beverages businesses into a single company, said a Bloomberg report citing sources.
532301 TGBL 500800 TATACOFFEE TGBA TTAZF TTQQY TATAGLOBAL 500770 TTAEY TATACHEM

0
Tata Coffee Limited - Spurt in Volume

2018-07-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532301 TATACOFFEE

0
Tata Coffee Limited - Spurt in Volume

2018-07-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532301 TATACOFFEE

0
Tata Coffee Limited - Shareholders meeting

2018-07-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532301 TATACOFFEE

0
Tata plans to merge food and beverage businesses

2018-07-03 livemint
Mumbai: Tata Group, India’s biggest conglomerate, is evaluating a proposal to integrate its food and beverage businesses into a single company, people with knowledge of the matter said.
532301 TGBL 500800 TATACOFFEE TGBA TTAZF TTQQY TATAGLOBAL 500770 TTAEY TATACHEM

1
An evening walk down Dalal Street: Sensex rallies over 100 points; Nifty ends around 10,700

2018-07-03 moneycontrol
The S&P BSE Sensex recovered sharply from opening lows and closed with gains of over 100 points on Tuesday while the Nifty50 witnessed a touch and go moment with 10,700 levels.
500116 TGBA 500800 TATACOFFEE TTAZF IDBI ALBK 532967 KIRIINDUS ABAN CNRYY TTAEY 532301 TGBL 532483 HDB 500180 532480 HDFCBANK CANBK 523204 TATAGLOBAL

0
Tata Coffee Limited - Trading Window

2018-06-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532301 TATACOFFEE

0
Tata Coffee Limited - Updates

2018-06-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532301 TATACOFFEE

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...